Actinium Pharmaceuticals Inc. (Delaware) (ATNM)
Symbol Info
Listed Symbol ATNM
Name Actinium Pharmaceuticals Inc. (Delaware)
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $-
Latest Fiscal EPS $-0.22
Price Info
21 Day Moving Average $0.2273
21 Day EMA $0.229640
50 Day Moving Average $0.2387
50 Day EMA $0.247770
200 Day EMA $0.379150
200 Day Moving Average 0.403380
52 Week High $0.87
52 Week Low $0.19
52 Week Change $-63.178300
Alpha -0.039399
Beta 1.6941
Standard Deviation 0.224753
R2 0.069584
Periods 60
Share Information
10 Day Average Volume 1,156,371
20 Day Average Volume 904,511
30 Day Average Volume 892,364
50 Day Average Volume 806,461
Outstanding Shares 162,425,600
Float Shares 161,996,752
Percent Float 99.74%
Short Interest 4,127,750
Short Percent Float 2.50%
Short Interest Ratio 5.96
Short Date 2019-07-31
Holders
Institutions 60
Institute Holdings Date 2019-07-31
Institute Bought Previous 3 Months 7,735,456
Institute Holdings Percent 11.100000
Institute Sold Previous 3 Months 1,746,135
Insider Holdings Date 2019-07-31
Insider Bought Previous 3 Months 10
Insider Holdings Percent 0.30%
Insider Sold Previous 3 Months -
Insiders Shares Owned 428,848
Price Change
7 Day Price Change $0.0325000
7 Day Percent Change 15.85%
21 Day Price Change $-0.0005
21 Day Percent Change -0.21%
30 Day Price Change $-0.03
30 Day Percent Change -11.22%
Month To Date Price Change $0.0047
Month To Date Percent 2.02%
90 Day Price Change $-0.045
90 Day Percent Change -15.93%
Quarter To Date $-0.0085
Quarter To Date Percent -3.46%
180 Day Price Change $-0.3817
180 Day Percent Change -61.64%
200 Day Price Change $-0.3424
200 Day Percent Change -59.04%
Year To Date $-0.1495
Year To Date Percent -38.63%
Profile
Description Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells safely and effectively. Its most advanced products are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
Details
Issue Type CS
Market Cap $38,576,080
Sec Type EQS
Auditor Marcum LLP
Total Shares Outstanding 162,425,600
CEO Sandesh Seth
Employees 30
Last Audit UE
Classification
CIK 0001388320
Industry Biotechnology
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 275 Madison Avenue
7th Floor
New York, NY 10016
Website https://www.actiniumpharma.com
Facisimile +1 845 818-3588
Telephone +1 646 677-3870
Email investorrelations@actiniumpharma.com
Key Ratios
Profitability
EBIT Margin -
EBITDA Margin -
Pre-Tax Profit Margin -
Profit Margin Cont -
Gross Margin -
Profit Margin TOT -
Income Statements
Revenue $-
Revenue Per Share $-
Revenue 3 Years $-
Revenue 5 Years $-
Valuation Measures
PE Ratio -
Enterprise Value $22,454,506
Price To Sales -
Price To Free Cash -1.9
PE High Last 5 Years -
Price To Book 2.6
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book 2.6
Financial Strength
Total Debt To Equity 0.1
Int Coverage -
Current Ratio 3.9
Leverage Ratio 1.6
Quick Ratio 3.8
Long Term Debt To Capital 0.06
Assets
Receivables Turnover -
Invoice Turnover -
Assets Turnover -
Management Effectiveness
Return Assets -104.34
Return On Equity -140.31
Return On Capital -130.23
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
AMEX
ATNM
Actinium P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.